Somatic mutations of the L12a gene in V-κ1 light chain deposition disease: Potential effects on aberrant protein conformation and deposition

Ruben Vidal, Fernando Goñi, Fred Stevens, Pierre Aucouturier, Asok Kumar, Blas Frangione, Jorge Ghiso, Gloria Gallo

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Light chain deposition disease (LCDD) and light chain amyloidosis (AL) are disorders of monoclonal immunoglobulin deposition in which normally soluble serum precursors form insoluble deposits in tissues. A common feature in both is the clonal proliferation of B-cells that produce pathogenic light chains. However, the deposits in LCDD differ from those in AL in that they are ultrastructurally granular rather than fibrillar and do not bind Congo red or colocalize with amyloid P component or apolipoprotein E. The reason(s) for their differences are unknown but are likely multifactorial and related to their protein conformation and their interaction with other molecules and tissue factors in the microenvironment. Knowledge of the primary structure of the light chains in LCDD is very limited. In the present study two new κ1 light chains from patients with LCDD are described and compared to seven other reported κ-LCDD proteins. The N-terminal amino acid sequences of light chain GLA extracted from the renal biopsy and light chain CHO from myocardial tissue were each identical to the respective light chains isolated from the urines and to the V-region amino acid sequences translated from the cloned cDNAs obtained from bone marrow cells. The germline V-region sequences, determined from the genomic DNA in both and in MCM, a previously reported κ1 LCDD light chain, were identical and related to the L12a germline gene. The expressed light chains in all three exhibit amino acid substitutions that arise from somatic mutation and result in increased hydrophobicity with the potential for protein destabilization and disordered conformation.

Original languageEnglish (US)
Pages (from-to)2009-2017
Number of pages9
JournalAmerican Journal of Pathology
Volume155
Issue number6
StatePublished - Dec 1999
Externally publishedYes

Fingerprint

Protein Conformation
Light
Mutation
Genes
Amyloidosis
Amino Acid Sequence
Serum Amyloid P-Component
Congo Red
Thromboplastin
Apolipoproteins E
Amino Acid Substitution
Hydrophobic and Hydrophilic Interactions
Bone Marrow Cells
Immunoglobulins

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Somatic mutations of the L12a gene in V-κ1 light chain deposition disease : Potential effects on aberrant protein conformation and deposition. / Vidal, Ruben; Goñi, Fernando; Stevens, Fred; Aucouturier, Pierre; Kumar, Asok; Frangione, Blas; Ghiso, Jorge; Gallo, Gloria.

In: American Journal of Pathology, Vol. 155, No. 6, 12.1999, p. 2009-2017.

Research output: Contribution to journalArticle

Vidal, R, Goñi, F, Stevens, F, Aucouturier, P, Kumar, A, Frangione, B, Ghiso, J & Gallo, G 1999, 'Somatic mutations of the L12a gene in V-κ1 light chain deposition disease: Potential effects on aberrant protein conformation and deposition', American Journal of Pathology, vol. 155, no. 6, pp. 2009-2017.
Vidal, Ruben ; Goñi, Fernando ; Stevens, Fred ; Aucouturier, Pierre ; Kumar, Asok ; Frangione, Blas ; Ghiso, Jorge ; Gallo, Gloria. / Somatic mutations of the L12a gene in V-κ1 light chain deposition disease : Potential effects on aberrant protein conformation and deposition. In: American Journal of Pathology. 1999 ; Vol. 155, No. 6. pp. 2009-2017.
@article{ff2c1e318bfc4b8c82a1e72309c3ff2f,
title = "Somatic mutations of the L12a gene in V-κ1 light chain deposition disease: Potential effects on aberrant protein conformation and deposition",
abstract = "Light chain deposition disease (LCDD) and light chain amyloidosis (AL) are disorders of monoclonal immunoglobulin deposition in which normally soluble serum precursors form insoluble deposits in tissues. A common feature in both is the clonal proliferation of B-cells that produce pathogenic light chains. However, the deposits in LCDD differ from those in AL in that they are ultrastructurally granular rather than fibrillar and do not bind Congo red or colocalize with amyloid P component or apolipoprotein E. The reason(s) for their differences are unknown but are likely multifactorial and related to their protein conformation and their interaction with other molecules and tissue factors in the microenvironment. Knowledge of the primary structure of the light chains in LCDD is very limited. In the present study two new κ1 light chains from patients with LCDD are described and compared to seven other reported κ-LCDD proteins. The N-terminal amino acid sequences of light chain GLA extracted from the renal biopsy and light chain CHO from myocardial tissue were each identical to the respective light chains isolated from the urines and to the V-region amino acid sequences translated from the cloned cDNAs obtained from bone marrow cells. The germline V-region sequences, determined from the genomic DNA in both and in MCM, a previously reported κ1 LCDD light chain, were identical and related to the L12a germline gene. The expressed light chains in all three exhibit amino acid substitutions that arise from somatic mutation and result in increased hydrophobicity with the potential for protein destabilization and disordered conformation.",
author = "Ruben Vidal and Fernando Go{\~n}i and Fred Stevens and Pierre Aucouturier and Asok Kumar and Blas Frangione and Jorge Ghiso and Gloria Gallo",
year = "1999",
month = "12",
language = "English (US)",
volume = "155",
pages = "2009--2017",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Somatic mutations of the L12a gene in V-κ1 light chain deposition disease

T2 - Potential effects on aberrant protein conformation and deposition

AU - Vidal, Ruben

AU - Goñi, Fernando

AU - Stevens, Fred

AU - Aucouturier, Pierre

AU - Kumar, Asok

AU - Frangione, Blas

AU - Ghiso, Jorge

AU - Gallo, Gloria

PY - 1999/12

Y1 - 1999/12

N2 - Light chain deposition disease (LCDD) and light chain amyloidosis (AL) are disorders of monoclonal immunoglobulin deposition in which normally soluble serum precursors form insoluble deposits in tissues. A common feature in both is the clonal proliferation of B-cells that produce pathogenic light chains. However, the deposits in LCDD differ from those in AL in that they are ultrastructurally granular rather than fibrillar and do not bind Congo red or colocalize with amyloid P component or apolipoprotein E. The reason(s) for their differences are unknown but are likely multifactorial and related to their protein conformation and their interaction with other molecules and tissue factors in the microenvironment. Knowledge of the primary structure of the light chains in LCDD is very limited. In the present study two new κ1 light chains from patients with LCDD are described and compared to seven other reported κ-LCDD proteins. The N-terminal amino acid sequences of light chain GLA extracted from the renal biopsy and light chain CHO from myocardial tissue were each identical to the respective light chains isolated from the urines and to the V-region amino acid sequences translated from the cloned cDNAs obtained from bone marrow cells. The germline V-region sequences, determined from the genomic DNA in both and in MCM, a previously reported κ1 LCDD light chain, were identical and related to the L12a germline gene. The expressed light chains in all three exhibit amino acid substitutions that arise from somatic mutation and result in increased hydrophobicity with the potential for protein destabilization and disordered conformation.

AB - Light chain deposition disease (LCDD) and light chain amyloidosis (AL) are disorders of monoclonal immunoglobulin deposition in which normally soluble serum precursors form insoluble deposits in tissues. A common feature in both is the clonal proliferation of B-cells that produce pathogenic light chains. However, the deposits in LCDD differ from those in AL in that they are ultrastructurally granular rather than fibrillar and do not bind Congo red or colocalize with amyloid P component or apolipoprotein E. The reason(s) for their differences are unknown but are likely multifactorial and related to their protein conformation and their interaction with other molecules and tissue factors in the microenvironment. Knowledge of the primary structure of the light chains in LCDD is very limited. In the present study two new κ1 light chains from patients with LCDD are described and compared to seven other reported κ-LCDD proteins. The N-terminal amino acid sequences of light chain GLA extracted from the renal biopsy and light chain CHO from myocardial tissue were each identical to the respective light chains isolated from the urines and to the V-region amino acid sequences translated from the cloned cDNAs obtained from bone marrow cells. The germline V-region sequences, determined from the genomic DNA in both and in MCM, a previously reported κ1 LCDD light chain, were identical and related to the L12a germline gene. The expressed light chains in all three exhibit amino acid substitutions that arise from somatic mutation and result in increased hydrophobicity with the potential for protein destabilization and disordered conformation.

UR - http://www.scopus.com/inward/record.url?scp=0344146434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344146434&partnerID=8YFLogxK

M3 - Article

C2 - 10595931

AN - SCOPUS:0344146434

VL - 155

SP - 2009

EP - 2017

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 6

ER -